[go: up one dir, main page]

HK1091141B - 恢復her2拮抗劑的治療法的敏感性的合成物和方法 - Google Patents

恢復her2拮抗劑的治療法的敏感性的合成物和方法 Download PDF

Info

Publication number
HK1091141B
HK1091141B HK06112976.7A HK06112976A HK1091141B HK 1091141 B HK1091141 B HK 1091141B HK 06112976 A HK06112976 A HK 06112976A HK 1091141 B HK1091141 B HK 1091141B
Authority
HK
Hong Kong
Prior art keywords
her2
pcdgf
antagonist
antibody
accession number
Prior art date
Application number
HK06112976.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1091141A1 (zh
Inventor
Ginette Serrero
Original Assignee
A & G Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & G Pharmaceutical, Inc. filed Critical A & G Pharmaceutical, Inc.
Priority claimed from PCT/US2004/024593 external-priority patent/WO2005011590A2/en
Publication of HK1091141A1 publication Critical patent/HK1091141A1/zh
Publication of HK1091141B publication Critical patent/HK1091141B/zh

Links

HK06112976.7A 2003-08-01 2004-07-30 恢復her2拮抗劑的治療法的敏感性的合成物和方法 HK1091141B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49153603P 2003-08-01 2003-08-01
US60/491,536 2003-08-01
US54779104P 2004-02-27 2004-02-27
US60/547,791 2004-02-27
PCT/US2004/024593 WO2005011590A2 (en) 2003-08-01 2004-07-30 Compositions and methods for restoring sensitivity to treatment with her2 antagonists

Publications (2)

Publication Number Publication Date
HK1091141A1 HK1091141A1 (zh) 2007-01-12
HK1091141B true HK1091141B (zh) 2014-04-11

Family

ID=

Similar Documents

Publication Publication Date Title
JP7301106B2 (ja) 線維芽増殖因子受容体２に対するモノクローナル抗体
US7815906B2 (en) Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
TWI432452B (zh) 針對ｈｅｒ-３之抗體類及其用途
US9783456B1 (en) Method for inhibiting cell growth using anti-ErbB-3 and anti-ErbB-2 antibodies
BR112019025188A2 (pt) Anticorpos anti-pdl1 ativáveis e métodos de uso dos mesmos
CN115023227B (zh) 用于治疗癌症的PD-1拮抗剂、VEGFR/FGFR/RET酪氨酸激酶抑制剂和CBP/β-联蛋白抑制剂的组合
CN110882385A (zh) 抗pd-1抗体在治疗肿瘤中的用途
CN113196061A (zh) 肉瘤样肾癌的诊断和治疗方法
CN112585166A (zh) 用pd-1轴结合拮抗剂、铂剂和拓扑异构酶ii抑制剂治疗肺癌的方法
CN112839644A (zh) 用pd-1轴结合拮抗剂、抗代谢物和铂剂治疗肺癌的方法
WO2014169494A1 (zh) 特异性识别egfr突变蛋白的单克隆抗体、制备方法及其应用
TW202104899A (zh) 三陰性乳癌之診斷及治療方法
US20080145369A1 (en) Autocrine Growth Factor Receptors and Methods
HK1091141B (zh) 恢復her2拮抗劑的治療法的敏感性的合成物和方法
CA2459622C (en) Compositions and methods for restoring sensitivity to treatment with her2 antagonists
HK40053242A (zh) 肉瘤样肾癌的诊断和治疗方法
HK40050244A (zh) 用pd-1轴结合拮抗剂、铂剂和拓扑异构酶ii抑制剂治疗肺癌的方法
WO2010096289A2 (en) Combination therapy using an anti-egfr agent(s) and igf-1r specific antibodies
HK40053012A (zh) 用pd-1轴结合拮抗剂、抗代谢物和铂剂治疗肺癌的方法
JPWO1999060025A1 (ja) 遺伝子組換え抗体